Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents.
about
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancerInhibition of heat-shock protein 90 reduces Ebola virus replicationExploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug designHeat-shock protein 90 promotes nuclear transport of herpes simplex virus 1 capsid protein by interacting with acetylated tubulinHsp90 inhibitors as new leads to target parasitic diarrheal diseases.Solid-phase parallel synthesis of a tetrahydroindazolone library containing three unique core skeletons.Probing the probes: fitness factors for small molecule tools.Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluationThermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90Macrocyclic drugs and synthetic methodologies toward macrocyclesThree-component synthesis of C2F5-substituted pyrazoles from C2F5CH2NH2·HCl, NaNO2 and electron-deficient alkynes.Design, synthesis, and evaluation of small molecule Hsp90 probes.Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.A systematic protocol for the characterization of Hsp90 modulators.HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma.Hsp90, an unlikely ally in the war on cancer.Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.Reverse the Resistance to PARP Inhibitors.Current status of agents active against the T315I chronic myeloid leukemia phenotype.Macrocycles in new drug discovery.Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.Applications of Palladium-Catalyzed C-N Cross-Coupling Reactions.Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oxime.Efficient MW-Assisted Synthesis, Spectroscopic Characterization, X-ray and Antioxidant Properties of Indazole Derivatives.A highly selective Hsp90 affinity chromatography resin with a cleavable linker.2-Acyl-dimedones as UV-active protective agents for chiral amino acids: enantiomer separations of the derivatives on chiral anion exchangers.Identification of Hsp90 inhibitors with anti-Plasmodium activity.Synthesis and Activity of a New Series of Antileishmanial Agents.Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer.Metabolism elucidation of BJ-B11 (a heat shock protein 90 inhibitor) by human liver microsomes: identification of main contributing enzymes.Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS).P-glycoprotein (P-gp)-mediated efflux limits intestinal absorption of the Hsp90 inhibitor SNX-2112 in ratsOne-pot synthesis of polysubstituted 3-acylpyrroles by cooperative catalysisSynthesis of 5,6-dihydro-4H -benzo[d ]isoxazol-7-one and 5,6-dihydro-4H -isoxazolo[5,4-c ]pyridin-7-one Derivatives as Potential Hsp90 Inhibitors
P2860
Q28264693-40FE4E75-1699-4C57-8B01-CE47BBD61EADQ28281834-0A0BA3CF-08AD-432A-8943-C2C63CCFD2F8Q28534499-CFF25884-1A1A-45DF-BEBD-9453312059A3Q28539444-D3FAAFC4-B0E3-4D1E-8004-2D3D7270755CQ33798454-F8F6310E-8904-4485-8104-C014C43E033BQ33906867-F6743381-DDE8-457E-B8F7-6BC8E4AB648BQ34001269-E68BDF4E-4CCB-4448-9D6C-F894518E7D8FQ34102029-74FEF083-5DF8-4C26-938D-F6C840948E34Q34288879-BE9D843D-C1A4-4926-90F6-F95F9CD35A94Q34740721-B131B495-5F82-4E37-8BA1-E5F63C307872Q35031035-9E6A779D-C47E-42D3-8BF8-A8A1F595A925Q35128528-F0CD18DF-8086-49CC-AA1C-05935C9CB2D9Q35800838-E69734A3-5BA0-4F0A-B41B-48AF5628A431Q36201554-3C41B771-72CE-439D-82BC-00992A3FEB09Q37060950-C1953341-0756-482F-B70D-DE1FA84FF0BEQ37274497-10FD6677-A304-4126-83B8-BA059ED709CCQ37622446-8862B3BC-1443-4197-8D3D-464D5578CB0EQ37675896-FEE30A4F-213C-466B-A793-B2AC8CF0A10FQ37847179-F61A2359-979C-4F9E-8461-68689788E4E9Q38031632-2D0D5BD9-FD8E-4D2F-906F-555FB6116B87Q38469746-B48E86ED-CA6C-45B9-A8A3-A1B91081C329Q38655003-F722C5A6-E45D-404A-A443-E9023AA0574EQ38735183-A2F6023A-3334-4B24-B923-34D37DEEEF9FQ38848546-9C9E5329-C0CE-4134-9591-E197329955E0Q38968855-0D76B286-4D3B-4FAC-94F5-20715465323AQ39002157-FE346686-22F3-47DF-B1D4-80071E66BA31Q39606990-FBC8B7A4-F5E9-4118-ACE8-A178F6333A20Q42149303-63463C5C-E605-4E9B-A756-239E20443A03Q43800530-65EE85D5-70AC-4164-A09D-ED40FDDBCFDCQ48022253-1929ABB7-9ABF-401D-9BD2-EA4DC06ABC1FQ53098554-A6E536F4-E9CB-4419-BD0B-7DD3291119B8Q53225323-9E7A5754-890C-466C-A233-A330F68785D3Q53467993-411B9FF6-656A-4649-A387-A6B08729C0BEQ54660067-7ECF1390-194F-4061-A8FD-80177A7B052AQ57109918-04E9C0A5-A2CB-44CD-92E8-ABE37E128AA7Q57844126-21A2D671-B570-4CD7-8DD4-A6AAD1939A11Q59080586-3BB585C9-430C-4D15-98E4-36E5EF3B1EF0
P2860
Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Discovery of novel 2-aminobenz ...... rally active antitumor agents.
@ast
Discovery of novel 2-aminobenz ...... rally active antitumor agents.
@en
type
label
Discovery of novel 2-aminobenz ...... rally active antitumor agents.
@ast
Discovery of novel 2-aminobenz ...... rally active antitumor agents.
@en
prefLabel
Discovery of novel 2-aminobenz ...... rally active antitumor agents.
@ast
Discovery of novel 2-aminobenz ...... rally active antitumor agents.
@en
P2093
P356
P1476
Discovery of novel 2-aminobenz ...... rally active antitumor agents.
@en
P2093
Amy F Barabasz
Andy J Ommen
Angela R Woodward
Anisa Scott
Bert Pronk
Briana E Foley
Christopher J Markworth
Emilie D Smith
Gunnar J Hanson
James M Veal
P304
P356
10.1021/JM900230J
P407
P577
2009-07-01T00:00:00Z